329 related articles for article (PubMed ID: 35402257)
1. A Comprehensive Analysis of the Glutathione Peroxidase 8 (GPX8) in Human Cancer.
Ren Z; He Y; Yang Q; Guo J; Huang H; Li B; Wang D; Yang Z; Tian X
Front Oncol; 2022; 12():812811. PubMed ID: 35402257
[TBL] [Abstract][Full Text] [Related]
2. The overexpression of GPX8 is correlated with poor prognosis in GBM patients.
Li S; Jiang X; Guan M; Zhang Y; Cao Y; Zhang L
Front Genet; 2022; 13():898204. PubMed ID: 36061208
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry and Bioinformatics Identify GPX8 as a Potential Prognostic Biomarker and Target in Human Gastric Cancer.
Zhang X; Xu H; Zhang Y; Sun C; Li Z; Hu C; Zhao D; Guo C
Front Oncol; 2022; 12():878546. PubMed ID: 35712475
[TBL] [Abstract][Full Text] [Related]
5. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value and immunological role of PTPN21 in pan-cancer analysis.
Yang Y; Yang W; Su X; Cheng C
Cent Eur J Immunol; 2023; 48(2):111-125. PubMed ID: 37692032
[TBL] [Abstract][Full Text] [Related]
7. Glutathione peroxidase family and survival prognosis in patients with renal cell carcinoma.
Li J; Huo S; Zhang R; Shi C; Sun N; Liu Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):562-572. PubMed ID: 35753726
[TBL] [Abstract][Full Text] [Related]
8. A Pan-Cancer Analysis of the Oncogenic Role of
Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
Front Genet; 2022; 13():906174. PubMed ID: 35910232
[No Abstract] [Full Text] [Related]
9. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of
Bai J; Zheng A; Ha Y; Xu X; Yu Y; Lu Y; Zheng S; Shen Z; Luo B; Jie W
Front Mol Biosci; 2022; 9():988777. PubMed ID: 36188228
[No Abstract] [Full Text] [Related]
11. PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma.
Wang J; Wu N; Feng X; Liang Y; Huang M; Li W; Hou L; Yin C
Front Immunol; 2022; 13():1052692. PubMed ID: 36685506
[TBL] [Abstract][Full Text] [Related]
12. Stromal Interaction Molecule 1 (STIM1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Solid Tumors.
Zhang Z; Wang Z; Liu Y; Zhao L; Fu W
J Environ Pathol Toxicol Oncol; 2023; 42(2):11-30. PubMed ID: 36749087
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer.
Zhao W; Lin J; Cheng S; Li H; Shu Y; Xu C
PeerJ; 2023; 11():e14645. PubMed ID: 36919165
[TBL] [Abstract][Full Text] [Related]
14. GRN is a prognostic biomarker and correlated with immune infiltration in glioma: A study based on TCGA data.
Xu SM; Xiao HY; Hu ZX; Zhong XF; Zeng YJ; Wu YX; Li D; Song T
Front Oncol; 2023; 13():1162983. PubMed ID: 37091137
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme.
Ye Y; Zhong W; Qian J; Zhang J; Xu T; Han R; Han J; Wang C; Song L; Zeng X; Wang H
Front Cell Dev Biol; 2023; 11():1042490. PubMed ID: 36711038
[No Abstract] [Full Text] [Related]
16. Comprehensive Analysis of Glutamate-Rich WD Repeat-Containing Protein 1 and Its Potential Clinical Significance for Pancancer.
Wu Y; Wu X; Li Y; Zhao W; Yue Y; Wu B; Liu J; Chen X; Shen A
Biomed Res Int; 2021; 2021():8201377. PubMed ID: 34616846
[TBL] [Abstract][Full Text] [Related]
17. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
[TBL] [Abstract][Full Text] [Related]
18. A pan-cancer analysis of the prognostic implication and oncogenic role of tubulin epsilon and delta complex 2 (TEDC2) in human tumors.
Liu Y; Zhu J; Shen J; Lu Y; Pan K; Tong C; Wang Y
Front Immunol; 2023; 14():1272108. PubMed ID: 38239349
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 (TIPE2): A potential novel pan-cancer immune checkpoint.
Bai KH; Zhang YY; Li XP; Tian XP; Pan MM; Wang DW; Dai YJ
Comput Struct Biotechnol J; 2022; 20():5226-5234. PubMed ID: 36187930
[TBL] [Abstract][Full Text] [Related]
20. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
Front Oncol; 2020; 10():570819. PubMed ID: 33628726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
